Recruiting Parkinsons Disease Studies in Washington D.c.
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease...
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson'...
About Parkinsons Disease Clinical Trials in Washington D.c.
Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.
There are currently 2 parkinsons disease clinical trials recruiting participants in Washington D.c., DC. These studies are seeking a combined 189 participants. Research is being sponsored by BlueRock Therapeutics, AskBio Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Parkinsons Disease Clinical Trials in Washington D.c. — FAQ
Are there parkinsons disease clinical trials in Washington D.c.?
Yes, there are 2 parkinsons disease clinical trials currently recruiting in Washington D.c., DC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Washington D.c.?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washington D.c. research site will contact you about next steps.
Are clinical trials in Washington D.c. free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washington D.c. studies also compensate for your time and travel.
What parkinsons disease treatments are being tested?
The 2 active trials in Washington D.c. are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.
Data updated March 2, 2026 from ClinicalTrials.gov